1334 related articles for article (PubMed ID: 33046850)
1. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.
Tschöpe C; Ammirati E; Bozkurt B; Caforio ALP; Cooper LT; Felix SB; Hare JM; Heidecker B; Heymans S; Hübner N; Kelle S; Klingel K; Maatz H; Parwani AS; Spillmann F; Starling RC; Tsutsui H; Seferovic P; Van Linthout S
Nat Rev Cardiol; 2021 Mar; 18(3):169-193. PubMed ID: 33046850
[TBL] [Abstract][Full Text] [Related]
2. Association of Viruses in the Development of Cardiovascular Diseases.
Rauff B; Malik A; Bhatti YA; Chudhary SA; Fatima K; Rafiq S; Tahir A; Sharif S; Qadri I
Curr Pharm Des; 2021; 27(37):3913-3923. PubMed ID: 33902408
[TBL] [Abstract][Full Text] [Related]
3. Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction.
Figulla HR
Med Microbiol Immunol; 2004 May; 193(2-3):61-4. PubMed ID: 14595559
[TBL] [Abstract][Full Text] [Related]
4. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
Hendren NS; Drazner MH; Bozkurt B; Cooper LT
Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
[TBL] [Abstract][Full Text] [Related]
5. Dilated cardiomyopathy update: infectious-immune theory revisited.
Kawai C; Matsumori A
Heart Fail Rev; 2013 Nov; 18(6):703-14. PubMed ID: 23892949
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Cardiomyopathic Syndromes.
Trachtenberg BH; Hare JM
Circ Res; 2017 Sep; 121(7):803-818. PubMed ID: 28912184
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.
Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412
[TBL] [Abstract][Full Text] [Related]
8. Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment.
Escher F; Tschöepe C; Lassner D; Schultheiss HP
Turk Kardiyol Dern Ars; 2015 Dec; 43(8):739-48. PubMed ID: 26717340
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular consequences of viral infections: from COVID to other viral diseases.
Schultheiss HP; Baumeier C; Pietsch H; Bock CT; Poller W; Escher F
Cardiovasc Res; 2021 Nov; 117(13):2610-2623. PubMed ID: 34609508
[TBL] [Abstract][Full Text] [Related]
10. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Prognosis of Suspected Myocarditis and Cardiomyopathy Associated with Viral Infection of the Myocardial Tissue: A Meta-Analysis of Cohort Studies.
Chen WH; Guo YS; Zhang DH; Zhang HJ
Cardiovasc Ther; 2019; 2019():9342792. PubMed ID: 31921354
[TBL] [Abstract][Full Text] [Related]
12. Overview on chronic viral cardiomyopathy/chronic myocarditis.
Schultheiss HP; Kühl U
Ernst Schering Res Found Workshop; 2006; (55):3-18. PubMed ID: 16329654
[TBL] [Abstract][Full Text] [Related]
13. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
14. [Myocardial disease in viral infections. Myocarditis--cardiomyopathy].
Brehm M
Med Klin (Munich); 2006 Mar; 101 Suppl 1():36-9. PubMed ID: 16802516
[TBL] [Abstract][Full Text] [Related]
15. [Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].
Kuhn H; Lawrenz T; Beer G
Med Klin (Munich); 2005 Sep; 100(9):553-61. PubMed ID: 16170644
[TBL] [Abstract][Full Text] [Related]
16. Myocarditis and dilated cardiomyopathy: possible connections and treatments.
Castellano G; Affuso F; Di Conza P; Fazio S
J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064
[TBL] [Abstract][Full Text] [Related]
17. Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report.
Nejadrahim R; Khademolhosseini S; Kavandi H; Hajizadeh R
J Med Case Rep; 2021 Mar; 15(1):143. PubMed ID: 33741059
[TBL] [Abstract][Full Text] [Related]
18. Viral myocarditis--diagnosis, treatment options, and current controversies.
Pollack A; Kontorovich AR; Fuster V; Dec GW
Nat Rev Cardiol; 2015 Nov; 12(11):670-80. PubMed ID: 26194549
[TBL] [Abstract][Full Text] [Related]
19. Management of Myocarditis-Related Cardiomyopathy in Adults.
Tschöpe C; Cooper LT; Torre-Amione G; Van Linthout S
Circ Res; 2019 May; 124(11):1568-1583. PubMed ID: 31120823
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic.
Shaboodien G; Maske C; Wainwright H; Smuts H; Ntsekhe M; Commerford PJ; Badri M; Mayosi BM
Cardiovasc J Afr; 2013 Jul; 24(6):218-23. PubMed ID: 23775037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
